Skip to main content

RHUMBLINE ADVISERS

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in FULC

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$507,562
-$122,552 QoQ
Shares Held
66,175
+18.8% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 168 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 15.8579523989422.ToString("F0")% Shared 0.ToString("F0")% None 84.1420476010578.ToString("F0")%

Common Shares in FULC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $1,238,262,141 across 282 Biotechnology names. FULC ranks #154 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FULC

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $507,562 66,175
2025-12-31 $630,114 55,713
2025-09-30 $638,222 69,372
2025-06-30 $572,760 83,250
2025-03-31 $256,299 88,993
2024-12-31 $416,452 88,607
2024-09-30 $311,332 87,208
2024-06-30 $566,878 91,432
2024-03-31 $15,642 1,657
2023-12-31 $11,184 1,657
2023-09-30 $7,357 1,657
2023-06-30 $15,810 4,791
2023-03-31 $215,194 75,507
2022-12-31 $434,834 59,730
2022-09-30 $410,381 50,727
2022-06-30 $232,882 47,527
2022-03-31 $806,819 34,115
2021-12-31 $560,896 31,707
2021-09-30 $851,913 30,199
2021-06-30 $235,538 22,475
2021-03-31 $145,541 12,355
2020-12-31 $138,939 11,865
2020-09-30 $84,176 10,615
2020-06-30 $232,740 12,725